159 related articles for article (PubMed ID: 36931700)
21. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
22. Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation.
Neitzel C; Seiwert N; Göder A; Diehl E; Weber C; Nagel G; Stroh S; Rasenberger B; Christmann M; Fahrer J
Cells; 2019 Jul; 8(8):. PubMed ID: 31366086
[TBL] [Abstract][Full Text] [Related]
23. Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells.
Kalimutho M; Minutolo A; Grelli S; Federici G; Bernardini S
Acta Pharmacol Sin; 2011 Nov; 32(11):1387-96. PubMed ID: 21927014
[TBL] [Abstract][Full Text] [Related]
24. Verbascoside promotes apoptosis by regulating HIPK2-p53 signaling in human colorectal cancer.
Zhou L; Feng Y; Jin Y; Liu X; Sui H; Chai N; Chen X; Liu N; Ji Q; Wang Y; Li Q
BMC Cancer; 2014 Oct; 14():747. PubMed ID: 25282590
[TBL] [Abstract][Full Text] [Related]
25. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
26. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.
Shi X; Chen Z; Hu X; Luo M; Sun Z; Li J; Shi S; Feng X; Zhou C; Li Z; Yang W; Li Y; Wang P; Zhou F; Gao Y; He J
Oncotarget; 2016 Jun; 7(24):36407-36418. PubMed ID: 27172796
[TBL] [Abstract][Full Text] [Related]
27. Ajuba Overexpression Promotes Breast Cancer Chemoresistance and Glucose Uptake through TAZ-GLUT3/Survivin Pathway.
Li X; Zhao G; Mi X; Xu T; Li X; Liu B
Biomed Res Int; 2022; 2022():3321409. PubMed ID: 35178446
[TBL] [Abstract][Full Text] [Related]
28. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
Tanaka I; Osada H; Fujii M; Fukatsu A; Hida T; Horio Y; Kondo Y; Sato A; Hasegawa Y; Tsujimura T; Sekido Y
Oncogene; 2015 Jan; 34(1):73-83. PubMed ID: 24336325
[TBL] [Abstract][Full Text] [Related]
29. AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer.
Bi L; Ma F; Tian R; Zhou Y; Lan W; Song Q; Cheng X
Gene; 2018 Feb; 644():148-154. PubMed ID: 29126926
[TBL] [Abstract][Full Text] [Related]
30. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
31. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
32. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
Wu X; Lu Y; Qin X
J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer.
Deng X; Li S; Kong F; Ruan H; Xu X; Zhang X; Wu Z; Zhang L; Xu Y; Yuan H; Peng H; Yang D; Guan M
Theranostics; 2020; 10(1):265-280. PubMed ID: 31903119
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
Lu M; Wang C; Wang J
Int J Oncol; 2016 Aug; 49(2):603-10. PubMed ID: 27279458
[TBL] [Abstract][Full Text] [Related]
35. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
36. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
37. Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency.
Din FV; Stark LA; Dunlop MG
Br J Cancer; 2005 Mar; 92(6):1137-43. PubMed ID: 15770215
[TBL] [Abstract][Full Text] [Related]
38. GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis.
Wang D; Wei X; Chen X; Wang Q; Zhang J; Kalvakolanu DV; Guo B; Zhang L
Exp Cell Res; 2021 Oct; 407(1):112799. PubMed ID: 34461110
[TBL] [Abstract][Full Text] [Related]
39. MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma.
Fu D; Pfannenstiel L; Demelash A; Phoon YP; Mayell C; Cabrera C; Liu C; Zhao J; Dermawan J; Patil D; DeVecchio J; Kalady M; Souers AJ; Phillips DC; Li X; Gastman B
Cell Death Dis; 2022 Jan; 13(1):63. PubMed ID: 35042842
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor functions of miR-133a in colorectal cancer.
Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
